[1]
Denova, L. 2022. The value of proteomic studies of the latest markers of kidney damage in the urine to assess the course, progression and complications in patients with CKD. KIDNEYS. 11, 2 (Jul. 2022), 68–80. DOI:https://doi.org/10.22141/2307-1257.11.2.2022.363.